PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 4.690
-0.170 (-3.50%)
Oct 9, 2026, 4:08 PM HKT
PegBio Market Cap
PegBio has a market cap or net worth of 1.83 billion as of October 9, 2026. It is the 20,019th most valuable company in the world and the 899th biggest in Hong Kong. Its market cap has decreased by 90.89% in one year.
Market Cap
1.83B
Enterprise Value
1.54B
Revenue
n/a
Global Rank
Country Rank
#899 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since May 27, 2025, PegBio's market cap has decreased from 4.46B to 1.83B, a decrease of -58.89%. That is a compound annual growth rate of -47.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.83B | -93.20% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 2.32B |
| Frontage Holdings | 2.25B |
| AIM Vaccine | 2.20B |
| Antengene Corporation | 2.19B |
| Mabpharm | 2.08B |
| HighTide Therapeutics | 1.96B |
| Shandong Boan Biotechnology | 1.93B |
| Beijing Biostar Pharmaceuticals | 1.68B |